OPPapers.com Essay Index >> Business >> Geneone Problem Solution
We have many free term papers and essays on Geneone Problem Solution. We also have a wide variety of research papers and book reports available to you for free. You can browse our collection of term papers or use our search engine.
GeneOne Problem Solution. Problem Solution: GeneOne Gene One is a cutting edge biotech
company that has grown into a $400 million company in just eight years. ...
GeneOne problem Solution. Problem Solution: Gene One Gene One entered the
biotech industry with groundbreaking gene technology that ...
... Running head: PROBLEM SOLUTION: GENEONE Problem Solution: GeneOne xxxxx University
of Phoenix Problem Solution: GeneOne GeneOne is a biotechnology firm that is ...
... Running head: PROBLEM SOLUTION: GENEONE Problem Solution: Gene One Roy Carter
University of Phoenix April 23, 2007 Problem Solution: Gene One Does there exist ...
... Running head: PROBLEM SOLUTION: GENEONE Problem Solution: GeneOne Your Name Goes
Here University of Phoenix Problem Solution: GeneOne [Triple click anywhere in ...
Submitted by sfcjpu on April 16, 2008
Category: Business
Words: 3908 | Pages: 16
Views: 169
Popularity Rank: 63,044
Average Member Grade: N/A (Add a Comment / Grade this Paper)
Problem Solution: GeneOne
Gene One is a cutting edge biotech company that has grown into a $400 million company in just eight years. Accordingly, sharply rising stock on Wall Street has indicated a growing interest in the biotechnology industry. Leadership changes at the Food and Drug Administration has also increased the confidence many investors have in the industry. In order to remain successful the Chief Executive Officer, Don Ruiz, and the Executive Board believe that in order to obtain the capital needed for development, advertising, and marketing, they will need to go public. They feel the time is right go public within the next 36 months and their goal is to continue to grow at 40% per year.
Situation Analysis
Issue and Opportunity Identification
The decision to go public has created many opportunities for Gene One, including increased brand recognition and market potential, increased capital for cutting-edge research and development, the potential to reward loyal employees and executives for their commitment to the company, and the ability to grow into a bio-tech industry leader. However, in order to realize these opportunities, certain problems also come up and must be addressed.
Don Ruiz and his current core management team have been with the company since Gene One was founded. They have many strengths; including a Chief Technology Officer (CTO), Teri Robertson, who has developed the core technology that has made the company successful. They have been working together for many years, and they have a very personal stake in Gene One and its future.
Gene One has been experienced considerable growth over the past eight years after developing a new gene technology that eliminated disease in tomatoes and potatoes. As a result, farmers no longer need to use pesticides when growing these plants and consumers were pleased to buy homegrown products uncontaminated by chemicals. This growth has...
You must Login to view the entire paper.
If you are not a member yet, Sign Up for free!